1-4 of 4
Sandra M. Wear, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Unfavorable Cytogenetic Characteristics Do Not Adversely Impact Response Rates in Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Single-Agent Carfilzomib on the 003 (A1) Study

Andrzej J Jakubowiak, MD, PhD, David S. Siegel, MD, PhD, Seema Singhal, MD, Thomas Martin, MD, Sagar Lonial, MD, Vishal Kukreti, MD, FRCPC, Nizar Bahlis, MD, Asher Alban Chanan-Khan, Melissa Alsina, MD, George Somlo, MD, Francis K Buadi, M.D., Frederic J. Reu, MD, Kevin W. Song, MD, Lori Kunkel, MD, Sandra M. Wear, RN, Alvin F. Wong, PharmD, Robert Z. Orlowski, MD, PhD, A. Keith Stewart, MBA, MB, CHB, Sundar Jagannath, MD, Luhua Wang, MD
Journal: Blood
Blood (2011) 118 (21): 1875.
https://doi.org/10.1182/blood.V118.21.1875.1875
Published: 2011
Journal Articles

Vantage 095: Vorinostat in Combination with Bortezomib in Salvage Multiple Myeloma Patients: Final Study Results of a Global Phase 2b Trial

David S. Siegel, MD, PhD, Meletios Athanasios Dimopoulos, MD, Sung-Soo Yoon, MD, PhD, Jacob P. Laubach, MD, Jonathan L. Kaufman, MD, Hartmut Goldschmidt, MD, Donna E. Reece, MD, FRCPC, Xavier Leleu, MD, PhD, Simon Durrant, MBBS, FRCP, FRCPath, Fritz C. Offner, MD, PhD, Michele Cavo, MD, Arnon Nagler, MD, Sundar Jagannath, MD, Thorsten Graef, MD, PhD, Jennifer Houp, Linda Sun, PhD, Jason Howe, Sandra M. Wear, RN, Kenneth C. Anderson, MD
Journal: Blood
Blood (2011) 118 (21): 480.
https://doi.org/10.1182/blood.V118.21.480.480
Published: 2011
Journal Articles

Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)

Andrzej J Jakubowiak, MD, PhD, Dominik Dytfeld, MD, PhD, Sundar Jagannath, MD, David H. Vesole, MD, PhD, Tara B. Anderson, Brian K. Nordgren, Kristen Detweiler-Short, Daniel Lebovic, MD, Keith E. Stockerl-Goldstein, MD, Kent A. Griffith, Terri L. Jobkar, BSN, Diane E Durecki, BA, Sandra M. Wear, RN, Robert F Ott, MBA, Ammar Al-Zoubi, MD, Melissa A Mietzel, M.S. CCRP, M Hussein, Daniel Couriel, MD, Joseph A Leveque, MD, Ravi Vij, MD
Journal: Blood
Blood (2011) 118 (21): 631.
https://doi.org/10.1182/blood.V118.21.631.631
Published: 2011
Journal Articles

The Multiple Myeloma Research Consortium (MMRC): Accelerated Start up and Accrual Metrics Speeds Drug Development

Sandra M. Wear, RN, Paul G. Richardson, MD, Carolyn Revta, MPH, Ravi Vij, MD, Mark Fiala, BS, Sagar Lonial, MD, Alaina R. Mitchell, BS, David S. Siegel, MD, PhD, Adolfo Aleman, CCRP, Andrzej J Jakubowiak, MD, PhD, Diane E Durecki, BA, Donna E. Reece, MD, FRCPC, Engin Gul, HonBSc, Ajai Chari, MD, Sundar Jagannath, MD, Lisa La, MS, Craig C. Hofmeister, MD, Mindy A Bowers, BS, A. Keith Stewart, MBA, MB, CHB, Rachel Hagerty, Jeffrey L. Wolf, MD, Geraldine Pelle-Day, Ph.D., Amrita Krishnan, MD, Lupe Duarte, CCRC, Todd M. Zimmerman, MD, Daniel Larsen, BS, Shaji Kumar, MD, Ann Birgin, CRA, Noopur S. Raje, MD, Vivek Roy, M.D., Michele Maharaj, RN, Joseph W. Fay, MD, Tracey Messing, RN, Robert F Ott, MBA, Leah Tasca, BA, Kenneth C. Anderson, MD, Kathy Giusti, MBA
Journal: Blood
Blood (2011) 118 (21): 1024.
https://doi.org/10.1182/blood.V118.21.1024.1024
Published: 2011